Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA.

Bochnakian A, Zhen A, Zisoulis DG, Idica A, KewalRamani VN, Neel N, Daugaard I, Hamdorf M, Kitchen S, Lee K, Pedersen IM.

J Virol. 2019 Sep 30;93(20). pii: e00364-19. doi: 10.1128/JVI.00364-19. Print 2019 Oct 15.

PMID:
31341054
2.

miR-128 Restriction of LINE-1 (L1) Retrotransposition Is Dependent on Targeting hnRNPA1 mRNA.

Fung L, Guzman H, Sevrioukov E, Idica A, Park E, Bochnakian A, Daugaard I, Jury D, Mortazavi A, Zisoulis DG, Pedersen IM.

Int J Mol Sci. 2019 Apr 21;20(8). pii: E1955. doi: 10.3390/ijms20081955.

3.

miR-128 inhibits telomerase activity by targeting TERT mRNA.

Guzman H, Sanders K, Idica A, Bochnakian A, Jury D, Daugaard I, Zisoulis DG, Pedersen IM.

Oncotarget. 2018 Jan 19;9(17):13244-13253. doi: 10.18632/oncotarget.24284. eCollection 2018 Mar 2.

4.

MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1.

Idica A, Sevrioukov EA, Zisoulis DG, Hamdorf M, Daugaard I, Kadandale P, Pedersen IM.

J Biol Chem. 2017 Dec 15;292(50):20494-20508. doi: 10.1074/jbc.M117.807677. Epub 2017 Oct 3.

5.

miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells.

Daugaard I, Sanders KJ, Idica A, Vittayarukskul K, Hamdorf M, Krog JD, Chow R, Jury D, Hansen LL, Hager H, Lamy P, Choi CL, Agalliu D, Zisoulis DG, Pedersen IM.

Oncogenesis. 2017 Jul 31;6(7):e366. doi: 10.1038/oncsis.2017.66.

6.

Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a.

Riess M, Fuchs NV, Idica A, Hamdorf M, Flory E, Pedersen IM, K├Ânig R.

J Biol Chem. 2017 Jan 6;292(1):264-277. doi: 10.1074/jbc.M116.752584. Epub 2016 Dec 1.

7.

Donor-Specific HLA Antibodies: A Review of Data Published in 2016.

Idica A, Everly MJ.

Clin Transpl. 2016;32:13-22. Review.

PMID:
28564519
8.

miR-128 represses L1 retrotransposition by binding directly to L1 RNA.

Hamdorf M, Idica A, Zisoulis DG, Gamelin L, Martin C, Sanders KJ, Pedersen IM.

Nat Struct Mol Biol. 2015 Oct;22(10):824-31. doi: 10.1038/nsmb.3090. Epub 2015 Sep 14.

PMID:
26367248
9.

Effect of amino acid mismatch in the UNOS dataset.

Sasaki N, El-Awar N, Idica A.

Clin Transpl. 2011:299-309.

PMID:
22755423
10.

Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients.

Trivedi HL, Terasaki PI, Feroz A, Vanikar AV, Trivedi VB, Khemchandani SI, Dave SD, Shankar V, Modi PR, Kaneku H, Idica A, Everly MJ.

Transplantation. 2010 Jul 27;90(2):221-2. doi: 10.1097/TP.0b013e3181dde912. No abstract available.

PMID:
20644455
11.
12.

Abrogation of anti-HLA antibodies via proteasome inhibition.

Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.

Transplantation. 2009 May 27;87(10):1555-61. doi: 10.1097/TP.0b013e3181a4b91b.

PMID:
19461494
13.

Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients.

Trivedi HL, Kaneku H, Terasaki PI, Feroz A, Vanikar AV, Trivedi VB, Khemchandani SI, Dave SD, Modi PR, Jahr F, Idica A, Everly MJ.

Clin Transpl. 2009:265-80.

PMID:
20524291
14.

Mimetic human leukocyte antigen epitopes: shown by monoclonal antibodies and extra antibodies produced on transplantation.

Sasaki N, Idica A, Terasaki PI.

Transplantation. 2008 Oct 15;86(7):912-8. doi: 10.1097/TP.0b013e318183783b.

PMID:
18852655
15.

Effect of amino acid mismatch in the UNOS 2007 dataset.

Sasaki N, Idica A, Hall B, Terasaki P.

Clin Transpl. 2007:241-54.

PMID:
18642455
16.

Is there a differential strength of specific HLA mismatches in kidney transplants?

Sasaki N, Idica A, Terasaki P.

Transplant Proc. 2008 May;40(4):1091-4. doi: 10.1016/j.transproceed.2008.03.023.

PMID:
18555121
17.

Unexpected frequencies of HLA antibody specificities in the sera of pre-transplant kidney patients.

Idica A, Sasaki N, Hardy S, Terasaki P.

Clin Transpl. 2006:161-70.

PMID:
18365376
18.

Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients.

Idica A, Sasaki N, Hardy S, Terasaki P.

Clin Transpl. 2006:139-59.

PMID:
18365375
19.

HLA matching by amino acid/positions in double and triple combinations.

Idica A, Sasaki N, Terasaki P.

Clin Transpl. 2006:123-38.

PMID:
18365374
21.

Elimination of post-transplant donor-specific HLA antibodies with bortezomib.

Idica A, Kaneku H, Everly MJ, Trivedi HL, Feroz A, Vanikar AV, Shankar V, Trivedi VB, Modi PR, Khemchandani SI, Dave SD, Terasaki PI.

Clin Transpl. 2008:229-39.

PMID:
19708459
22.

Donor-specific HLA antibody response in clonal deletion.

Kaneku H, Idica A, Everly MJ, Terasaki PI, Feroz A, Vanikar AV, Shankar V, Trivedi VB, Modi PR, Khemchandani SI, Dave SD, Trivedi HL.

Clin Transpl. 2008:189-98.

PMID:
19708456
23.

Automatic segmentation of histological structures in mammary gland tissue sections.

Fernandez-Gonzalez R, Deschamps T, Idica A, Malladi R, Ortiz de Solorzano C.

J Biomed Opt. 2004 May-Jun;9(3):444-53.

24.

System for combined three-dimensional morphological and molecular analysis of thick tissue specimens.

Fernandez-Gonzalez R, Jones A, Garcia-Rodriguez E, Chen PY, Idica A, Lockett SJ, Barcellos-Hoff MH, Ortiz-De-Solorzano C.

Microsc Res Tech. 2002 Dec 15;59(6):522-30. Review.

Supplemental Content

Support Center